17th ANNUAL CONFERENCE of the German Society for Neuromodulation

German Neuromodulation Conference

Between the 4th and 5th of November, we’ll be at the 17th ANNUAL CONFERENCE of the German Society for Neuromodulation at: Victor’s Residenz-Hotel GeraBerliner Strasse 3807545 Gera More information here: https://www.medical-communications.de/veranstaltungen/17-jahrestagung-der-deutschen-gesellschaft-fuer-neuromodulation-ev

MRI Approval for directSTIM™ DBS System

MRI Labeling DBS

Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System Lausanne, Switzerland, 14 September 2022 – Aleva Neurotherapeutics SA, the company that pioneered Directional Deep Brain Stimulation (DBS) in Neuromodulation, announces the CE approval of its MRI labeling for the directSTIM™ DBS System, to be used in a full-body magnetic resonance imaging […]

We’re Hiring – Software Engineer & Project Manager

In order to support our continued growth, we are looking for a Medical Device Software Project Manager and a Software Engineer. Medical Device Software Project Manager: Bachelor degree in Computer Science (or related field) with at least 9 years of experience or Master’s degree with at least 7 years of related experience (HES or EPFL). […]

FDA Grants Aleva Approval for IDE Study

FDA - DBS System

U.S. FDA grants Aleva Neurotherapeutics approval for an Investigational Device Exemption (IDE) study on directSTIM™ Directional Deep Brain Stimulation System Aleva is committed to starting the PMA trial in the next quarters, in parallel with the post-market clinical follow-up study currently underway in select European neurological clinics. The US trial will include up to 15 […]